Odonate Therapeutics Inc is a US-based pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer. The company mainly focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs, taxanes, which are widely used in the treatment of cancer including breast cancer. The key product of the company is Tesetaxel which is a chemotherapy for oral administration with a low pill burden for various types of cancers.